Table 3.

Level of consensus on statements related to abrogation of systemic inflammation

Statements	Scores applied, n						Level of consensus, %
	1	2	3	4	5	Total
3.1 Psoriasis-related systemic inflammation can affect joints, liver, nervous system and cardiovascular system	0	0	5	6	17	28	100
3.2 Attention should be paid to early recognition of psoriatic arthritis	0	0	0	6	22	28	100
3.3 Moderate-to-severe psoriasis can be associated with various comorbidities that can benefit from, or be worsened by, anti-psoriatic therapy	0	0	5	5	18	28	100
3.4 Biological drugs showing a high selectivity in inhibiting inflammatory signals can improve comorbidities that share pathogenic pathways with psoriasis	0	2	3	8	15	28	93
3.5 In obese patients, body weight reduction may positively impact on overall response to anti-psoriatic therapy	0	0	2	8	18	28	100